Editas Medicine Inc (EDIT)
2.95
+0.04
(+1.37%)
USD |
NASDAQ |
Nov 04, 13:16
Editas Medicine Price to Book Value: 1.049 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.034 |
| October 31, 2024 | 1.031 |
| October 30, 2024 | 1.074 |
| October 29, 2024 | 1.106 |
| October 28, 2024 | 1.159 |
| October 25, 2024 | 1.130 |
| October 24, 2024 | 1.130 |
| October 23, 2024 | 1.141 |
| October 22, 2024 | 1.170 |
| October 21, 2024 | 1.337 |
| October 18, 2024 | 1.194 |
| October 17, 2024 | 1.177 |
| October 16, 2024 | 1.226 |
| October 15, 2024 | 1.194 |
| October 14, 2024 | 1.152 |
| October 11, 2024 | 1.134 |
| October 10, 2024 | 1.052 |
| October 09, 2024 | 1.109 |
| October 08, 2024 | 1.127 |
| October 07, 2024 | 1.141 |
| October 04, 2024 | 1.202 |
| October 03, 2024 | 1.138 |
| October 02, 2024 | 1.145 |
| October 01, 2024 | 1.162 |
| September 30, 2024 | 1.212 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.237 |
| September 26, 2024 | 1.241 |
| September 25, 2024 | 1.205 |
| September 24, 2024 | 1.255 |
| September 23, 2024 | 1.301 |
| September 20, 2024 | 1.340 |
| September 19, 2024 | 1.39 |
| September 18, 2024 | 1.379 |
| September 17, 2024 | 1.372 |
| September 16, 2024 | 1.362 |
| September 13, 2024 | 1.404 |
| September 12, 2024 | 1.333 |
| September 11, 2024 | 1.344 |
| September 10, 2024 | 1.340 |
| September 09, 2024 | 1.248 |
| September 06, 2024 | 1.276 |
| September 05, 2024 | 1.241 |
| September 04, 2024 | 1.244 |
| September 03, 2024 | 1.241 |
| August 30, 2024 | 1.330 |
| August 29, 2024 | 1.319 |
| August 28, 2024 | 1.308 |
| August 27, 2024 | 1.358 |
| August 26, 2024 | 1.394 |
| August 23, 2024 | 1.376 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.031
Minimum
Oct 31 2024
14.40
Maximum
Jan 08 2021
3.534
Average
2.341
Median
Sep 07 2022
Price to Book Value Benchmarks
| EyePoint Pharmaceuticals Inc | 2.785 |
| Cassava Sciences Inc | 6.583 |
| Regeneron Pharmaceuticals Inc | 3.144 |
| Vertex Pharmaceuticals Inc | 8.221 |
| Adverum Biotechnologies Inc | 0.9495 |
Price to Book Value Related Metrics
| PS Ratio | 3.605 |
| Price | 2.95 |
| Earnings Yield | -80.00% |
| Market Cap | 243.31M |